Auli Ropo Selected Research

tafluprost

1/2019	Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study.
1/2017	Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study.
1/2016	Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials.
1/2015	Intraocular pressure decrease with preservative-free fixed and unfixed combination of tafluprost and timolol in pseudoexfoliative glaucoma.
12/2014	A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components.
9/2014	Fixed-dose combination of tafluprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: comparison with other fixed-combination products.
8/2014	Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients.
5/2010	Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
2/2010	Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study.
2/2010	A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of Tafluprost compared with latanoprost.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Auli Ropo Research Topics

Disease

12	Glaucoma 07/2020 - 07/2005
11	Ocular Hypertension (Glaucoma, Suspect) 07/2020 - 01/2008
10	Open-Angle Glaucoma (Glaucoma, Open Angle) 07/2020 - 01/2008
4	Cataract (Cataracts) 03/2009 - 12/2003
3	Dry Eye Syndromes (Dry Eye Syndrome) 01/2016 - 05/2010
3	Hyperemia 01/2016 - 08/2007
2	Pruritus (Itching) 01/2016 - 05/2010
2	Foreign Bodies (Foreign Body) 01/2016 - 05/2010
2	Blepharitis 01/2016 - 05/2010
1	Exfoliation Syndrome 02/2010
1	Photophobia (Light Sensitivity) 08/2007
1	Stroke (Strokes) 07/2005
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 04/2004

Drug/Important Bio-Agent (IBA)

13	tafluprostIBA 01/2019 - 08/2007
11	Timolol (Blocadren)FDA LinkGeneric 01/2019 - 07/2005
10	Ophthalmic Solutions (Eye Drops)IBA 07/2020 - 12/2003
7	ProstaglandinsIBA 07/2020 - 01/2008
5	Latanoprost (Xalatan)FDA Link 07/2020 - 08/2007
4	HydrogelsIBA 02/2009 - 07/2005
3	Levofloxacin (Levaquin)FDA Link 03/2009 - 12/2003
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2016 - 05/2010
1	omidenepag isopropylIBA 07/2020
1	ProdrugsIBA 07/2020
1	Bimatoprost (Lumigan)FDA Link 01/2019
1	hydroxide ionIBA 01/2019
1	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2019
1	DuotravIBA 09/2014
1	GanfortIBA 09/2014
1	Prostaglandins FIBA 01/2008
1	SolutionsIBA 11/2006
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 07/2005
1	pemirolast (Alamast)FDA Link 04/2004
1	PotassiumIBA 04/2004
1	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2003

Therapy/Procedure

1	Therapeutics 03/2009